NDC 0378-0255-05 - Albuterol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0378-0255
- Requested NDC
- 0378-0255-05
- Package NDCs from labels
- 0378-0255-01, 0378-0255-05
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Effective date
- 2020-07-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Albuterol - Mylan Pharmaceuticals Inc. | Mylan Pharmaceuticals Inc. | 2020-07-30 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0378-0255-01 | EA - Each | 0378-0255 | 2a92a2fd-05c9-4944-87ac-360bff642496 | 1 | 2012-07-24 |
| 0378-0255-05 | EA - Each | 0378-0255 | 511acfd7-97dc-49ba-acb1-bba9e552367e | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ALBUTEROL SULFATE | ACTIVE INGREDIENT | 021SEF3731 | ALBUTEROL (ALBUTEROL SULFATE) TABLET [MYLAN PHARMACEUTICALS INC.] | 5 | |
| ALBUTEROL | ACTIVE MOIETY | QF8SVZ843E | ALBUTEROL (ALBUTEROL SULFATE) TABLET [MYLAN PHARMACEUTICALS INC.] | 5 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | ALBUTEROL (ALBUTEROL SULFATE) TABLET [MYLAN PHARMACEUTICALS INC.] | 5 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | ALBUTEROL (ALBUTEROL SULFATE) TABLET [MYLAN PHARMACEUTICALS INC.] | 5 | |
| SODIUM LAURYL SULFATE | INACTIVE INGREDIENT | 368GB5141J | ALBUTEROL (ALBUTEROL SULFATE) TABLET [MYLAN PHARMACEUTICALS INC.] | 5 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | ALBUTEROL (ALBUTEROL SULFATE) TABLET [MYLAN PHARMACEUTICALS INC.] | 5 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ipratropium Bromide and Albuterol Sulfate | IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE | Chartwell RX, LLC | b444478a-10ce-484f-9039-6383dfb8161e | 2025-12-02 | Warnings, Adverse reactions | 021SEF3731 |
| Combivent Respimat | IPRATROPIUM BROMIDE AND ALBUTEROL | Boehringer Ingelheim Pharmaceuticals, Inc. | 9832312e-0310-4ab6-8501-afa976fc7eb2 | 2025-12-01 | Warnings, Adverse reactions | 021SEF3731 |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | Bryant Ranch Prepack | 378461f2-7271-44a3-9da3-b39970b65d3a | 2025-11-10 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | ASCLEMED USA INC. | 8ea40065-4f59-434f-9ea1-7ef006fde66e | 2025-11-07 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Asclemed USA, Inc. | 056e145b-87aa-4009-a7ab-2ac0bd086eb0 | 2025-11-06 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | NuCare Pharmaceuticals, Inc. | 2c3f975c-dbd8-0362-e063-6394a90a16dd | 2025-10-21 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | NuCare Pharmaceuticals,Inc. | 4120061a-dbae-8918-e063-6394a90afbf2 | 2025-10-14 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Preferred Pharmaceuticals, Inc. | 081b7bbb-6692-4512-b135-863b73bf30a5 | 2025-10-13 | Warnings, Adverse reactions | 021SEF3731 |
| AIRSUPRA | ALBUTEROL SULFATE AND BUDESONIDE | AstraZeneca Pharmaceuticals LP | e60aa9f9-5139-44df-b886-ebddc3c7eb13 | 2025-09-18 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulate HFA | ALBUTEROL SULFATE | NuCare Pharmaceuticals,Inc. | 825975b1-a4a9-78ca-e053-2a91aa0a3948 | 2025-09-02 | Warnings, Adverse reactions | 021SEF3731 |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | QUAGEN PHARMACEUTICALS LLC | 99a490cc-e41d-436b-9cf3-8facb7ac714f | 2025-07-03 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol sulfate | ALBUTEROL SULFATE | Preferred Pharmaceuticals, Inc. | 99782bc8-56d9-41f8-935e-0d0de27f0c34 | 2025-05-19 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Preferred Pharmaceuticals Inc. | 1c72fd84-7dbc-45d0-ab88-fb4221ce369f | 2025-05-16 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol sulfate | ALBUTEROL SULFATE | Asclemed USA, Inc. | 264e2145-c7d4-4f4f-aa5b-9fe48a7c5b47 | 2025-05-07 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol | ALBUTEROL | Bryant Ranch Prepack | 601a18ed-d66e-498f-a804-f1a3330827d4 | 2025-04-21 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | Proficient Rx LP | a6545fbe-b0a6-41ae-8bb6-91af38410f56 | 2025-04-01 | Warnings, Adverse reactions | 021SEF3731 |
| ALBUTEROL SULFATE | ALBUTEROL SULFATE | Chartwell RX, LLC | 560df50c-e2c4-459f-9d89-bf7e6588949e | 2025-03-28 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol | ALBUTEROL | Rising Pharma Holdings, Inc. | 40f3cdbc-c9ee-4a3c-8061-a44b9a1d035c | 2025-03-06 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol Sulfate | ALBUTEROL SULFATE | NuCare Pharmaceuticals,Inc. | 813d49be-3651-6759-e053-2991aa0a6a9f | 2025-02-06 | Warnings, Adverse reactions | 021SEF3731 |
| Albuterol sulfate | ALBUTEROL SULFATE | Lupin Pharmaceuticals, Inc. | 973b8686-c6ce-4280-85c4-c1e7ceab3c09 | 2025-01-23 | Warnings, Adverse reactions | 021SEF3731 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.